Metabolic Dysfunction-Associated Fatty Liver Disease in Advanced Chronic Kidney Disease: Impact on Patient Survival
MAFLD is highly prevalent in patients with ACKD, particularly among those with diabetes, for whom it may represent an independent risk factor for reduced survival. This association was not observed in non-diabetic ACKD patients. These results suggest the need to design preventive and treatment strategies for MAFLD in this population.
Authors
- Sandra Pérez Fernández
- Sara Afonso
- César García-Cantón
- Sara Aladro
- Jesús M. González‐Martín (ORCID: https://orcid.org/0000-0001-6816-4157)
- Domingo Hernández (ORCID: https://orcid.org/0000-0001-5469-2119)
- Antonio Tugores (ORCID: https://orcid.org/0000-0002-1849-9239)
- Fátima Batista
- Mauro Boronat (ORCID: https://orcid.org/0000-0001-8535-8543)
- Selene González (ORCID: https://orcid.org/0000-0001-8239-2105)
- Yaiza Rivero
- Elvira Bosch
- Sonia Guinea
Institutions
- Universidad de Las Palmas de Gran Canaria (ES)
- Universidad de La Laguna (ES)
- Hospital Universitario Insular de Gran Canaria (ES)
- Hospital Universitario de Canarias (ES)
- Fundación Canaria de Investigación Sanitaria (ES)
- Universidad de Málaga (ES)
Publication Details
- Journal
- The Nephron journals/Nephron journals
- Published
- 2025-05-24
- DOI
- https://doi.org/10.1159/000546525
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00